GSK

Uniting science, technology and talent to get ahead of disease together

GSK is changing. 

We expect to demerge our world leading consumer healthcare business, Haleon, in July 2022. After the demerger, we will be a fully focussed biopharma company with a new purpose; to unite science, technology and talent to get ahead of disease together.

For this reason, we have updated our branding to reflect our new purpose and growth ambitions. It combines science, technology and talent, while retaining key elements of our heritage. We aim to impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance. GSK will be a company where outstanding people can thrive.

Want to know more about this change ? Click HERE

 Subscribe to GSK on YouTube | Follow GSK on Twitter | Follow GSK on Instagram (see: Over the 5 years of the Comic Relief & GSK partnership) | Follow GSK on LinkedIn | Like GSK on Facebook